Escipra 15mg Tablet contains Escitalopram Oxalate, a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD). By inhibiting the reuptake of serotonin in the central nervous system, Escitalopram increases serotonin availability, thereby enhancing mood and reducing anxiety symptoms. Escipra is typically prescribed for adults and should be administered once daily, with or without food, as directed by a healthcare professional. The onset of therapeutic effects may take several weeks; therefore, adherence to the prescribed regimen is essential. Common adverse effects include nausea, headache, insomnia, dry mouth, and dizziness, which generally subside with continued use. Caution is advised in patients with a history of bipolar disorder, seizures, or suicidal ideation. Escipra should not be combined with monoamine oxidase inhibitors (MAOIs) or other serotonergic agents due to the risk of serotonin syndrome. Dose adjustments may be necessary in patients with hepatic or renal impairment. Pregnant and lactating women should use this medication only if the potential benefit justifies the potential risk to the fetus or infant. Regular monitoring by a healthcare provider is recommended to assess efficacy and safety during treatment with Escipra 15mg Tablet.